Phyton Biotech Revenue and Competitors

Dallas, TX USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Phyton Biotech's estimated annual revenue is currently $20.5M per year.(i)
  • Phyton Biotech's estimated revenue per employee is $155,000

Employee Data

  • Phyton Biotech has 132 Employees.(i)
  • Phyton Biotech grew their employee count by 6% last year.

Phyton Biotech's People

NameTitleEmail/Phone
1
Head Process DevelopmentReveal Email/Phone
2
Head Cell Culture DevelopmentReveal Email/Phone
3
Head R&DReveal Email/Phone
4
Director, Business Development Phyton BiotechReveal Email/Phone
5
Managing Director Phyton BiotechReveal Email/Phone
6
Chief Scientific Officer Phyton BiotechReveal Email/Phone
7
Managing Director Phyton BiotechReveal Email/Phone
8
Senior Director, Quality and Regulatory Affairs Phyton BiotechReveal Email/Phone
9
Human Resources ManagerReveal Email/Phone
10
Quality Assurance ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M11-8%N/AN/A
#2
$14.9M96-6%N/AN/A
#3
$15.2M983%$1.8MN/A
#4
$1.6M100%N/AN/A
#5
$3.4M220%N/AN/A
#6
$2.8M1850%N/AN/A
#7
$7.4M48-2%N/AN/A
#8
$0.8M50%N/AN/A
#9
$1.6M100%N/AN/A
#10
$16.3M10562%N/AN/A
Add Company

What Is Phyton Biotech?

Phyton Biotech is the world's leader in pharmaceutical plant cell fermentation (PCF®) technology. A global supplier of high quality oncology actives via PCF, our products are registered in every major country in the world. With state-of-the-art facilities near Hamburg and Vancouver, we also offer comprehensive development services via PCF for plant-based actives, complex small molecules, and a variety of products used in the treatment of cancer and other serious illnesses.

keywords:Biotechnology,Healthcare,Pharmaceuticals

N/A

Total Funding

132

Number of Employees

$20.5M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Phyton Biotech News

2022-04-20 - Paclitaxel Market Size And Forecast | Phyton Biotech ...

Phyton Biotech, Novasep, ScinoPharm Taiwan, Teva Pharmaceutical Industries Ltd., Samyang Biopharmaceuticals Corp.

2022-04-13 - Gorlin Syndrome Market to Exhibit Moderate Growth Rate till ...

... Investigates DelveInsight | Key Companies – Mayne Pharma, PellePharm, Leo Pharma, Phyton Biotech, HedgePath Pharma, and Others.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$28.1M1341%N/A
#2
$33.1M13524%N/A
#3
$7.5M13513%N/A
#4
$48M1365%N/A
#5
$20.4M136-7%N/A